ESR1 and hepatocellular carcinoma: Pathophysiological evidence further indicates altered sex hormone receptor profiles in HCC tissues, characterized by upregulated androgen receptor (AR) expression and diminished estrogen receptor (ER) levels (60) potentially compromising estrogen’s protective capacity.